{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:34:14Z","timestamp":1790393654403,"version":"4.1.0"},"reference-count":36,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2022,1,28]]},"DOI":"10.1080\/10428194.2021.1986217","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:57:49Z","timestamp":1634079469000},"page":"304-314","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial"],"prefix":"10.1080","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-1399","authenticated-orcid":false,"given":"Tara","family":"Cochrane","sequence":"first","affiliation":[{"name":"Department of Haematology, Gold Coast University Hospital","place":["Southport, Australia"]},{"name":"Griffiths University","place":["Parkwood, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1983-6145","authenticated-orcid":false,"given":"Alicia","family":"Enrico","sequence":"additional","affiliation":[{"name":"Area Hematology, Hospital Italiano La Plata","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"Gomez-Almaguer","sequence":"additional","affiliation":[{"name":"Hematology Service, Hospital Universitario, Universidad Aut\u00f3noma de Nuevo Le\u00f3n","place":["San Nicol\u00e1s de los Garza, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgueniy","family":"Hadjiev","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Medical University Sofia, University Hospital Alexandrovska","place":["Sofia, Bulgaria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Lech-Maranda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology and Transfusion Medicine","place":["Warsaw, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9038-302X","authenticated-orcid":false,"given":"Tamas","family":"Masszi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Haematology, Semmelweis University","place":["Budapest, Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2490-1263","authenticated-orcid":false,"given":"Eugene","family":"Nikitin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology and Chemotherapy, S. P. Botkin\u2019s City Hospital","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3411-6357","authenticated-orcid":false,"given":"Tadeusz","family":"Robak","sequence":"additional","affiliation":[{"name":"Medical University of Lodz and Copernicus Memorial Hospital","place":["Lodz, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-7988","authenticated-orcid":false,"given":"Robert","family":"Weinkove","sequence":"additional","affiliation":[{"name":"Wellington Blood & Cancer Centre, Capital & Coast District Health Board","place":["Wellington, New Zealand"]},{"name":"Cancer Immunotherapy Programme, Malaghan Institute of Medical Research","place":["Wellington, New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Ju","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Haematology, National Taiwan University Hospital","place":["Taipei City, Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita R.","family":"Sail","sequence":"additional","affiliation":[{"name":"AbbVie, Inc","place":["North Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7568-7762","authenticated-orcid":false,"given":"John","family":"Pesko","sequence":"additional","affiliation":[{"name":"AbbVie, Inc","place":["North Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Pai","sequence":"additional","affiliation":[{"name":"AbbVie, Inc","place":["North Chicago, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Komlosi","sequence":"additional","affiliation":[{"name":"AbbVie Schweiz AG","place":["Cham, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3515-0215","authenticated-orcid":false,"given":"Mary Ann","family":"Anderson","sequence":"additional","affiliation":[{"name":"The Clinical Haematology Department of the Royal Melbourne Hospital and Peter MacCallum Cancer Centre","place":["Parkville, Australia"]},{"name":"Division of Blood Cells and Blood Cancer, The Walter and Eliza Hall Institute","place":["Parkville, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1586\/era.11.132"},{"key":"e_1_3_4_3_1","unstructured":"National Cancer Institute. Cancer Stat Facts: leukemia \u2014 chronic lymphocytic leukemia (CLL); 2021 [cited 2021 Jan 11]. Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/clyl.html"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24826"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2020.1784120"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0257-2"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500244183"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13503"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1416364"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06791.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-015-1039-y"},{"issue":"2","key":"e_1_3_4_13_1","first-page":"185","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 4.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"18","author":"Wierda WG","year":"2020","unstructured":"Wierda WG, Byrd JC, Abramson JS, et\u00a0al. Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(2):185\u2013217.","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506654102"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800121105"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1714"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513257"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713976"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.6840"},{"key":"e_1_3_4_20_1","unstructured":"Zinzani P Jager U Lustgarten S et\u00a0al. Patient-reported outcomes and quality of life in DUO: a randomized trial of duvelisib vs. ofatumumab in patients with relapsed or refractory chronic lymphocytic leukemia\/small lymphocytic lymphoma. Presented at: European Hematology Association Virtual Congress; 2020."},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.238808"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1130"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1232-8"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1205217"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3761"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.36.15_suppl.7526"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.1.139"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00451727"},{"key":"e_1_3_4_31_1","unstructured":"Wierda W Sail K Noe L et\u00a0al. editors. Impact of venetoclax on the quality of life of patients with relapsed\/refractory chronic lymphocytic leukemia: results of a phase 2 open-label study of venetoclax (ABT-199\/GDC-0199) monotherapy. Presented at: European Hematology Association Congress; Madrid Spain; 2017."},{"key":"e_1_3_4_32_1","unstructured":"Wierda W Sail K Potluri J et\u00a0al. editors. Impact of venetoclax on the quality of life of CLL patients relapsed\/refractory to B-cell receptor (BCR) signaling pathway inhibitor treatment. Presented at: European Hematology Association Congress; Madrid Spain; 2017."},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","unstructured":"Cochrane T Chagorova T Robak T et\u00a0al. Venetoclax improves quality of life for patients with relapsed\/refractory chronic lymphocytic leukemia. Presented at: European Hematology Association Congress; Stockholm Sweden; 2018.","DOI":"10.1182\/blood-2018-99-117127"},{"key":"e_1_3_4_34_1","unstructured":"Kater A Arslan \u00d6 Demikran F et\u00a0al. Efficacy of venetoclax in patients with relapsed\/refractory chronic lymphocytic leukemia: primary endpoint analysis of the International Phase 3b Trial (VENICE I). Presented at: European Hematology Association Virtual Congress; 2020."},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30019-5"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.03.017"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.67"}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2021.1986217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:48:35Z","timestamp":1768207715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2021.1986217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,28]]}},"alternative-id":["10.1080\/10428194.2021.1986217"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2021.1986217","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}